Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
about
Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.Proteomic analysis of multiple myeloma: current status and future perspectives.Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis.Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.Primary study of lymph node metastasis-related serum biomarkers in breast cancer.New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic ProfileDetection of serum tumor markers in multiple myeloma using the CLINPROT system.Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.Evaluation of novel serum biomarkers and the proteomic differences of endometriosis and adenomyosis using MALDI-TOF-MS.A prognostic biomarker for gastric cancer with lymph node metastases.Establishing serological classification tree model in rheumatoid arthritis using combination of MALDI-TOF-MS and magnetic beads.Screening for specific biomarkers in the serum of postmenopausal osteoporosis patients using proteomic fingerprint techniques.Proteomic analysis for finding serum pathogenic factors and potential biomarkers in multiple myeloma.Head and neck cancer: proteomic advances and biomarker achievements.Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K/Akt/mTOR signaling pathway.Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome.
P2860
Q33747964-D906B33A-4834-4283-8CF9-7492CDE11DDEQ33807327-49F80E35-9744-4308-A300-916F84E3FEE2Q33846310-E5F9F60B-6350-4000-96E9-64B99358934AQ33930852-0CA19EFC-D3DE-4BA3-A7C6-E064012AE21BQ34020523-EDB05648-2A19-4C99-A905-96E443DE43CFQ34037335-6A80CF2B-EBDA-43E2-A0F8-C8B5CDD589F7Q34045656-D5F6951F-AFDB-413C-838E-F3E186C4C12CQ34121793-FA1C1205-1D31-4DCA-84CD-CE98FE7DBE47Q34249148-B735B7C0-21A5-4459-9FFD-54F0D304939BQ34281288-D59584F0-1AC3-4FC0-A437-F8A9E4995188Q34284870-9F84493D-24C9-4568-80DF-8FB7D906FE75Q34570578-4FBEE57F-E8D1-4C44-87AD-46DABE46A630Q34574653-01F86019-0B8E-4432-8974-43BE22392E8DQ35057228-7EE6B2DA-51D3-4877-80B1-279BD35A8AB8Q35125615-35A17299-283C-43C6-8C18-B4FC0EB32F57Q35604680-0700F6E0-3971-4EC9-9C9A-E3BEAF182EACQ37776208-F59EB780-2ACE-47AF-950A-080C31A8BD95Q42365262-2AB346E3-84B0-4105-9493-BC914FFB4C5EQ48115682-3F9067DE-3B29-4B04-B8BE-9B1309373AEB
P2860
Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Construction of a multiple mye ...... pattern recognition software.
@ast
Construction of a multiple mye ...... pattern recognition software.
@en
type
label
Construction of a multiple mye ...... pattern recognition software.
@ast
Construction of a multiple mye ...... pattern recognition software.
@en
prefLabel
Construction of a multiple mye ...... pattern recognition software.
@ast
Construction of a multiple mye ...... pattern recognition software.
@en
P2093
P356
P1476
Construction of a multiple mye ...... pattern recognition software.
@en
P2093
An-Ping Ni
Chao-Jun Hu
Guan-Fei Zhao
Jian Zhang
Qing-Tao Wang
Wen-Ming Chen
Yong-Zhe Li
Yu-Fang Liang
P2860
P304
P356
10.1002/AR.20871
P577
2009-04-01T00:00:00Z